No signs offailure appeared in the patients (ii from group I and 2 from group II) who were treated with the diuretic combined with antiadrenergic drugs. This combination restored to pretreatment levels the parameters of myocardial function which were disturbed by the administration of the antiadrenergic drugs alone.
Sustained systemic hypertension induces haemodynamic stress on the left ventricle. When the load on the heart is excessive, several compensatory mechanisms prevent circulatory decompensation: increase in the contractile state by the sympathetic nervous system is one of the principal mechanisms which maintain the circulation under chronic excessive loading.
Gaffney and Braunwald (I963) reported intensification of congestive failure in patients with valvular or primary myocardial disease after guanethidine therapy, and emphasized the need for caution in the use of effective antiadrenergic drugs in the treatment of patients with limited cardiac reserve. Dependent oedema, weight gain, and aggravation of heart failure were reported also in hypertensive subjects during treatment with guanethidine (Leishman, Matthews, and Smith, I959; Dollery, EmslieSmith, and Milne, I960; Smith, I965a) or reserpine (Perera, 1955;  Marley and Pare, I956; Smirk and McQueen, 1955; Smith, I965b) . In these patients
Received 26 June 1972. the degree of preceding cardiac impairment appeared to be related to the development of the untoward effects. In our experience we have been surprised by the occurrence of heart failure during guanethidine and reserpine administration in hypertensive patients with no history or clinical symptoms of circulatory decompensation. This might suggest that they had cardiac insufficiency in a latent stage, not detectable clinically, which was converted to overt failure by antiadrenergic treatment.
A method of assessing quantitatively the cardiac reserve in hypertension seems to be of theoretical and practical interest.
Digitalis increases the contractility of the failing as well of the nonfailing or normal heart (Kassebaum and Griswold, 1970) ; there seems, however, to be a correlation between the magnitude of the induced changes in haemodynamic parameters re-aspects of left ventricular function, were used as a tentative means of revealing reduced or borderline cardiac compensation in long-standing arterial hypertension.
Methods
The present study was carried out on 30 carefully selected men in hospital with primary arterial hypertension, who did not give a history nor had any clinical signs of heart failure. The latter were excluded by the usual clinical criteria, i.e. absence of oedema, basilar riles, radiological evidence of pulmonary congestion, increased venous pressure, or gallop rhythm. The functional capacity of each patient, based upon follow-up over 2 to 3 weeks before the study, was determined by using the criteria of the New York Heart Association (I964). All the patients had no or only mild exertional dyspnoea (functional class I or II). Cardiac size was estimated on the basis of physical examination and chest x-ray. A scale of i + (minimal enlargement) to 5 + (huge heart) was used. In order to deal with comparable cases in a homogeneous group, patients with valvular lesions, exertional angina, old myocardial infarction, or idiopathic myocardial disease in addition to hypertension, were excluded. Furthermore, only patients with a glomerular filtration rate above 50 ml/ min, who were in regular sinus rhythm, and had not received digitalis at any time in the past, or antihypertensive therapy for at least one month before entry were included.
The following protocol was used: after a follow-up of 2 to 3 weeks, the haemodynamic effects of the administration of ouabain were evaluated. Depending on the response, the patients were divided into two groups as follows: group I (non-responders) consisted of 22 patients in whom the changes in left ventricular mean rate of isovolumic pressure development and in mean rate of systolic ejection after digitalis were within io per cent of the control values. Group II (responders) consisted of 8 patients in whom digitalis resulted in a clear-cut increase (above 20%) both in mean rate of isovolumic pressure development and in mean rate of systolic ejection.
Six subjects out of the 8 in group II were randomly selected and treated according to an experimental design which included two periods. During the first period reserpine and guanethidine were administered, the daily dose of the former being o05 mg. The initial dose of the latter was 30 mg/day which was increased progressively until a hypotensive effect was achieved, both in the supine and standing position, or signs of left ventricular failure had become manifest. The maximal daily doses of guanethidine ranged between 40 and 6o mg, and the total duration of this treatment ranged between 13 and 17 days. During the second period a diuretic (chlorthalidone Ioo mg/day) was added. When necessary, the dose of the antiadrenergic agents was then reduced according to the degree of the hypotensive response. The lowest daily doses of reserpine and guanethidine after addition of diuretic were o025 mg and 25 mg, respectively.
Between the first and the second period the haemodynamic study was repeated and the effects of digitalis were again tested on each subject. In 3 of these patients the same procedure was again carried out, for the third time, after the addition of the diuretic. The remaining 2 patients of group II had the triple drug treatment only. In both of them, after an average period of 14 days, a satisfactory hypotensive effect was achieved. The haemodynamic study was then repeated and the effects of digitalis re-evaluated.
Of the 22 digitalis-unresponsive patients (group I), I]I were randomly selected and treated with reserpine and guanethidine, while the remainder had the triple drug combination including chlorthalidone. The doses of the drugs and the periods of treatment were in the same range as in group II. In each of these subjects the circulatory study was repeated after treatment had induced hypotensive responses, at which time the effect of digitalis was again re-evaluated.
One patient in group II interrupted the antihypertensive treatment a few weeks after being discharged. His blood pressure again became raised and he was readmitted to the hospital. The haemodynamic effects of acute intravenous infusion of reserpine (o 5 mg) combined to guanethidine (o03 mg/kg) were tested in this latter patient.
The circulatory changes induced by digitalis were also evaluated in 5 normal volunteers and in 4 hypertensive subjects with overt heart failure. The subjects gave their free consent to these investigations in the full knowledge of the procedure to be undertaken.
The haemodynamic studies were performed with the subjects in the fasting state without premedication. For the measurement of right atrial pressure a polyethylene 'floating' catheter (1-2 mm i.d.) was inserted into an antecubital vein, advanced to the right ventricle, and withdrawn under pressure-monitoring to the right atrium. An i8-gauge Teflon catheter needle, inserted into the brachial artery, was used to sample indocyanine green for cardiac output and to monitor arterial pressure. Pressures were determined with Statham P23 De and P24 Db strain gauge transducers. Dye dilution analyses of cardiac output were performed after injection of indocyanine green (5 mg) into the right atrium and withdrawal from the brachial artery. Blood withdrawn during inscription of the indicator dilution curves was immediately reinfused except for that small amount which was necessary for calibrating the densitometer at the end of the procedure. The output signal of the cuvette densitometer (Gilford) was coupled to the input of a digital computer (Gilford) Fig. i and 2) Fig. i and 2 ). The negative action of the antiadrenergic treatment and the favourable effects of the diuretic combination were even more evident in the circulatory pattern of three patients in group II, as shown in Table 4 , with a repeated study before (A) and after (B) antiadrenergic therapy, and after diuretic combination (C). Tables 5 and 6 refer to the non-responders to digitalis. Both the antiadrenergic agents alone (Table 5 ) and combined with diuretic (Table 6 ) resulted in effective lowering of the blood pressure. In none of these patients did either form of treatment induce clinical signs of cardiac decompensation. Parameters related to left ventricular function did not show significant reductions after antihypertensive therapy either with or without the diuretic combination. The response to digitalis remained in a similar range to that before treatment (see also Fig. i and 2 ). The patients in group I who were treated with reserpine and guanethidine had their body weight checked daily: no weight gain was detected.
A single intravenous infusion of reserpine and guanethidine in patient A.C. in group II induced a classical circulatory response (Cohn, Liptak, and Freis, I963), i.e. a transient pressor phase, followed by a later hypotensive response (mean arterial pressure decreased from i66 to I34 mmHg). The hypotensive effect was associated with a reduction in mean right atrial pressure (from 3.5 to Iv5 mmHg), an increase in cardiac index (from 2600 tO 3200 ml/min) as well as in the mean rates of left ventricular systolic ejection (from 8o to 93 ml/sec/M2) and isovolumic pressure development (from 3-2 to 3-7 mmHg/msec). Previous long-term administration of the same drugs had induced left ventricular failure in this patient. group.bmj.com on April 5, 2017 -Published by http://heart.bmj.com/ Downloaded from 6o Guazzi, Magrini, Fiorentini, and Polese The almost equal quantitative changes induced by digitalis on mean systolic ejection rate and mean rate of isovolumic pressure development ( Fig. i  and 2 ) in normals and hypertensive non-responders suggest that when the function of the heart is maintained, the effects of digitalis are very small and quite similar both in the normal and in the hypergroup.bmj.com on April 5, 2017 -Published by http://heart.bmj.com/ Downloaded from Sympathetic system and cardiac function in hypertension 6i 
Mean isovolumic pressure development rate 2-2 3-05 +42 I-6* 3-I* + 6ot A, before and B, after antiadrenergic therapy; C, after diuretic combination. %, per cent changes induced by digitalization. As regards the mechanism by which failure is induced, reserpine and guanethidine could depress cardiac performance either by interrupting the sympathetic drive to the heart, or by promoting fluid retention, or both. However, a dramatic improvement of dyspnoea was observed by Dollery et al. (I960) in a patient with acute pulmonary oedema who was given guanethidine. Cohn et al. (I963) found that intravenous infusion of guanethidine in hypertensive subjects with congestive heart failure improved cardiac function. The beneficial effect was thought to be the result of both a decrease in right atrial filling pressure due to increased capacity of the peripheral venous system and a reduction in systemic vascular resistance. These observations appear in contrast with the negative influence of guanethidine on cardiac function in our patients with a reduced margin of cardiac reserve. Cardiac failure occurred despite a considerable reduction in systemic vascular resistance. Patient A.C. may be of some interest here, because chronic administration of guanethidine and reserpine induced left ventricular failure, while his cardiac performance obviously improved after acute intravenous infusion of the same drugs. A reasonable explanation might be that the negative influence of fluid retention induced by chronic antiadrenergic treatment plus sympathetic blockade overwhelms the favourable effect of the reduced left ventricular afterload.
It is difficult to say whether fluid retention is a cause or a consequence of cardiac failure. On the basis of changes in body weight, the present observations suggest that fluid retention is more likely to occur in those patients who develop heart failure; however, the data are insufficient for any definite conclusion. It has been suggested that the fall in blood pressure, with its consequent effects on the renal circulation, is the cause of fluid retention produced by hypotensive drugs (R0nnov-Jessen, I955). In Smith's (I965b) series, the creatinine clearance values fell significantly in most of the patients treated with guanethidine. The author, however, considered it unwarranted to ascribe to this association a cause-and-effect relation. From our observations, the explanation of fluid retention occurring as a result of a fall in glomerular filtration rate consequent to fall in blood pressure seems unsatisfactory; in fact changes in glomerular filtration rate were insignificant, and in addition the hypotensive responses were approximately the same in group I and II patients.
No clinical or haemodynamic signs of cardiac failure were detected in patients who had the diuretic added to their regimen. Diuretics obviously were effective in preventing heart failure in 2 subjects in group II and in returning to the pretreatment levels the circulatory parameters of those subjects who developed cardiac decompensation after antiadrenergic therapy used alone. The reduction of volume load and of pressure load (potentiation of the hypotensive effect) on the heart may provide possible explanation of the improved cardiac performance observed after the diuretic.
